The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1374
October 3, 2011
View Complete Issue         Table of Contents 2019 
Issue 1374
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
In Brief: Duration of Use of Bisphosphonates
October 3, 2011 (Issue: 1374)
The FDA and two of its advisory committees have been debating whether to recommend limiting the duration of use of bisphosphonates in order to prevent atypical femoral fractures and possibly other side effects of the drugs. The agency produced a...more
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1374
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.